Biotech Market Analysis
Evaluating the commercial potential of emerging life science technologies and diagnostic tools for investors and startups.
Senior Consultant with expertise in molecular diagnostics, biotechnology, and strategic operations. Skilled in advanced data analytics, DNA analysis, financial modeling, and molecular biology.
Evaluating the commercial potential of emerging life science technologies and diagnostic tools for investors and startups.
Optimizing pipeline value and resource allocation for pharmaceutical companies to maximize ROI and therapeutic impact.
Streamlining Quality Management Systems (QMS) and regulatory pathways to accelerate time-to-market.
I am a dual-degree professional holding a PhD in Physical Chemistry from École Normale Supérieure and an MBA from Collège des Ingénieurs. My career blends deep scientific expertise with strong financial acumen and experience in regulatory affairs.
My passion lies in bridging the gap between life sciences and strategic finance, evaluating biotechnology innovations for market viability and investment potential.
Developing R&D portfolio go-to-market and optimization strategies for top pharmaceutical companies.
Acting QMS lead for a large pharmaceutical company. Designed strategic frameworks for improved operational efficiencies (~20%) in quality management systems.
Selected as a high-potential founder. Exploring personalised diagnostics and preventative healthcare with electrochemical biosensors and DNA computing.
Project Manager for the organisational transformation of 2400 employees enhancing productivity by ~10%. Futureproofed organisational health and improved decision-making structures.
"Innovative Strategies for DNA Analysis using Supramolecular Assemblies and qPCR Multiplexing". Named inventor of patented hcPCR multiplexing method.
Investments scout and content team community manager. Deal sourcing and community building.
Co-developed qPCR kits for COVID & respiratory viruses. Oversaw design, installation, and regulatory compliance of the chemistry lab.
Global pharma client needed to allocate a $1B+ R&D budget efficiently across high-risk assets.
Built a Python-based Monte Carlo simulation model to stress-test pipeline value and probability of success (PoS).
Identified $200M in efficiency gains; the model was adopted as the new global standard for portfolio review.
Existing DNA detection methods were too slow and unscalable for specific respiratory pathogens.
Developed a novel "hcPCR" supramolecular assembly method to multiplex detection without loss of sensitivity.
Named inventor on patent. Reduced detection time by 40% and published findings in a top-tier chemical journal.
From Dublin to Paris, Munich, and Bern—gaining a pan-European perspective.
4-year Executive-type MBA. Highly competitive admission rate (< 5%). Masterclasses from European industry executives.
Expertise developed in Analytical Physical Chemistry, Chemical Biology, Diagnostics and DNA nanotechnologies.
Research masters at the interface between chemistry and biology. 'Mention Très Bien' - 1st Class Honours achieved.
4-year honours degree program with a research thesis. 2nd Class Honours.
AI-Powered Biotech Investment Intelligence
A sophisticated platform delivering real-time analysis of the biotechnology sector. It leverages LLMs (Google Gemini) to parse SEC filings and news, generating sentiment scores and daily executive summaries for investors.
Intelligent Fasting & Metabolic Health Tracker
A data-driven fasting companion that uses AI to provide personalized health insights. Features include a dynamic fasting timer, metabolic stage tracking, and 'AuraPlan'—an AI scheduler that optimizes weekly fasting goals based on user patterns.
Founder. Leader of a biotech investment club with a 30% return rate.
Building the French alumni community of Collège des Ingénieurs, organizing TED Talk projects.
Developed an IoT software system for clinical bed management (MIT medical hackathon).
I'm based in Paris (3eme) and open to discussing opportunities in Strategy, Biotech, and Tech.
Email: glen.christopher.carter@gmail.com
Phone: +33 6 28 37 04 38